These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 26769715)

  • 1. Concurrent whole brain radiotherapy and RRx-001 for melanoma brain metastases.
    Kim MM; Parmar H; Cao Y; Knox SJ; Oronsky B; Scicinski J; Lawrence TS; Lao CD
    Neuro Oncol; 2016 Mar; 18(3):455-6. PubMed ID: 26769715
    [No Abstract]   [Full Text] [Related]  

  • 2. BRAINSTORM: A Multi-Institutional Phase 1/2 Study of RRx-001 in Combination With Whole Brain Radiation Therapy for Patients With Brain Metastases.
    Kim MM; Parmar HA; Schipper M; Devasia T; Aryal MP; Kesari S; O'Day S; Morikawa A; Spratt DE; Junck L; Mammoser A; Hayman JA; Lawrence TS; Tsien CI; Aiken R; Goyal S; Abrouk N; Trimble M; Cao Y; Lao CD
    Int J Radiat Oncol Biol Phys; 2020 Jul; 107(3):478-486. PubMed ID: 32169409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease presentation and outcome in young patients (<40 years) with brain metastases from malignant melanoma.
    Nieder C; Adam M; Astner ST
    Anticancer Res; 2008; 28(2B):1325-7. PubMed ID: 18505073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-brain radiation therapy in melanoma: an open question.
    Cranmer LD; Jeter JM; Morgan SS; Hersh EM; Stea B
    Lancet Oncol; 2010 Jan; 11(1):13; author reply 13-4. PubMed ID: 20129127
    [No Abstract]   [Full Text] [Related]  

  • 5. A Complete Metabolic Response of Metastatic Castration-resistant Neuroendocrine Carcinoma of the Prostate After Treatment with RRx-001 and Reintroduced Platinum Doublets.
    Brzezniak C; Oronsky B; Aggarwal R
    Eur Urol; 2018 Feb; 73(2):306-307. PubMed ID: 28943185
    [No Abstract]   [Full Text] [Related]  

  • 6. Cerebral metastases of malignant melanoma: contemporary treatment modalities and survival outcome.
    Panagiotou IE; Brountzos EN; Kelekis DA; Papathanasiou MA; Bafaloukos DI
    Neoplasma; 2005; 52(2):150-8. PubMed ID: 15800714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
    Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
    J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose escalation of whole-brain radiotherapy for brain metastases from melanoma.
    Rades D; Heisterkamp C; Huttenlocher S; Bohlen G; Dunst J; Haatanen T; Schild SE
    Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):537-41. PubMed ID: 19733017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rockets, radiosensitizers, and RRx-001: an origin story part I.
    Oronsky B; Scicinski J; Ning S; Peehl D; Oronsky A; Cabrales P; Bednarski M; Knox S
    Discov Med; 2016 Mar; 21(115):173-80. PubMed ID: 27115167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [CNS metastases in malignant melanomas].
    Willner J; Bohndorf W
    Strahlenther Onkol; 1995 Mar; 171(3):165-73. PubMed ID: 7709333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous in-field boost for brain metastases: in regard to Lagerwaard et al. (Int J Radiat Oncol Biol Phys 2009;75:253-259).
    Hallock A; Bauman G; Chen J; Yartsev S
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):964-5; author reply 965. PubMed ID: 20869584
    [No Abstract]   [Full Text] [Related]  

  • 12. From METS to malaria: RRx-001, a multi-faceted anticancer agent with activity in cerebral malaria.
    Yalcin O; Oronsky B; Carvalho LJ; Kuypers FA; Scicinski J; Cabrales P
    Malar J; 2015 May; 14():218. PubMed ID: 26017006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RRx-001: a systemically non-toxic M2-to-M1 macrophage stimulating and prosensitizing agent in Phase II clinical trials.
    Oronsky B; Paulmurugan R; Foygel K; Scicinski J; Knox SJ; Peehl D; Zhao H; Ning S; Cabrales P; Summers TA; Reid TR; Fitch WL; Kim MM; Trepel JB; Lee MJ; Kesari S; Abrouk ND; Day RM; Oronsky A; Ray CM; Carter CA
    Expert Opin Investig Drugs; 2017 Jan; 26(1):109-119. PubMed ID: 27935336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation necrosis of the brain in melanoma patients successfully treated with ipilimumab, three case studies.
    Du Four S; Wilgenhof S; Duerinck J; Michotte A; Van Binst A; De Ridder M; Neyns B
    Eur J Cancer; 2012 Nov; 48(16):3045-51. PubMed ID: 22727601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The treatment of brain metastases in melanoma patients.
    Bafaloukos D; Gogas H
    Cancer Treat Rev; 2004 Oct; 30(6):515-20. PubMed ID: 15325032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiotherapy of intracerebral metastatic malignant melanoma.
    Cooper JS; Carella R
    Radiology; 1980 Mar; 134(3):735-8. PubMed ID: 6153469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival following whole brain radiation treatment for cerebral metastases: an audit of 474 patients.
    Broadbent AM; Hruby G; Tin MM; Jackson M; Firth I
    Radiother Oncol; 2004 Jun; 71(3):259-65. PubMed ID: 15172140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition of cerebral metastases from malignant melanoma: implications for radiosurgery.
    Davey P; O'Brien P
    Neurosurgery; 1991 Jan; 28(1):8-14; discussion 14-5. PubMed ID: 1994286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of brain metastases in uncommon tumors.
    Tosoni A; Lumachi F; Brandes AA
    Expert Rev Anticancer Ther; 2004 Oct; 4(5):783-93. PubMed ID: 15485313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impressive regression of visceral and cerebral melanoma metastases under combination treatment including dacarbacine, radiotherapy and celecoxib.
    Becker MR; Gaiser T
    Int J Dermatol; 2009 Feb; 48(2):207-9. PubMed ID: 19200209
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.